Purified Salograviolide A isolated from Centaurea ainetensis causes growth inhibition and apoptosis in neoplastic epidermal cells

International Journal of Oncology

Volumn 32, Issue 4, 2008, Pages 841-849

  Ghantous, Akram ^a   Tayyoun, Ahmad Abou ^a   Lteif, Ghada Abou ^a   Saliba, Najat A ^a   Gali Muhtasib, Hala ^a   El Sabban, Marwan ^a   Darwiche, Nadine ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Plant extract; Salograviolide A; Skin cancer

Indexed keywords

CENTAUREA AINETENSIS EXTRACT; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; REACTIVE OXYGEN METABOLITE; SALOGRAVIOLIDE A; SESQUITERPENE LACTONE; ANTINEOPLASTIC AGENT; FUSED HETEROCYCLIC RINGS;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOASSAY; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CENTAUREA; CENTAUREA AINETENSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; EPIDERMIS CELL; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL CYCLE; CHEMISTRY; DRUG EFFECT; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELLS, CULTURED; CENTAUREA; HETEROCYCLIC COMPOUNDS, 3-RING; KERATINOCYTES; MICE; MICE, INBRED BALB C; NF-KAPPA B; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; SKIN NEOPLASMS;

EID: 44449157783     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Fauci AS, Braunwald E, Esselbach KJ, et al: Harrison's Principles of Internal Medicine. 14th edition. McGraw-Hill, New York, pp 1300-1309, 1998.
2. Federman DG, Kravetz JD and Kirsner RS: Skin cancer screening by dermatologists: prevalence and barriers. J Am Acad Dermatol 46: 710-714, 2002.
3. Koyama J, Morita I, Tagahara K, et al: Chemopreventive effects of emodin and cassiamin B in mouse skin carcinogenesis. Cancer Lett 182: 135-139, 2002.
4. Williamson EM: Synergy and other interactions in phyto-medicines. Phytomed 5: 401-409, 2001.
5. Mabberlay DJ: The Plant-Book. A portable dictionary of the vascular plants. 2nd edition. Cambridge University Press, Cambridge, p138, 1997.
6. Gurib-Fakim A: Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med 27: 1-93, 2006.
7. Koukoulitsa E, Skalta H, Karioti A, Demetzos C and Dimas K: Bioactive sesquiterpene lactones from Centaurea species and their cytotoxic/ cytostatic activity against human cell lines in vitro. Planta Med 68: 649-652, 2002.
8. Zhang S, Won YK, Ong CN and Shen HM: Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr Med Chem-Anti-Cancer Agents 5: 239-249, 2005.
9. Viguera Lobo JMY and Casabuena PA: Hypoglycemic action in the genus Centaurea II attempt at the separation of the active principle. Farmacognosia 13: 223-234, 1953.
10. Lee KH, Ibuka T, Wu RY and Geissman TA: Structure-antimicrobial activity relationship among the sesquiterpene lactones and related compounds. Phytochem 16: 1177-1181, 1977.
11. Giordano OS, Pestchanker MJ, Guerreiro E, et al: Structure-activity relationship in the gastric cytoprotective effect of several sesquiterpene lactones. J Med Chem 35: 2452-2458, 1992.
12. Kabbout M, Hatoum A, Abou-Lteif G, Chakroun I, Homaidan FR and Darwiche N: Stage-specific effect of N-(4-hydroxyphenyl) retinamide on cell growth in squamous cell carcinogenesis. Mol Carcinog 40: 12-23, 2004.
13. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K and Yuspa SH: Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19: 245-254, 1980.
14. Yuspa SH, Koehler B, Kulesz-Martin M and Hennings H: Clonal growth of mouse epidermal cells in medium with reduced calcium concentration. J Invest Dermatol 76: 144-146, 1981.
15. Ha oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 48: 165-169, 1988.
16. Greenhalgh DA, Welty DJ, Player A and Yuspa SH: Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma. Proc Natl Acad Sci 87: 643-647, 1990.
17. Yuspa SH, Kilkenny AE, Steinert PM and Roop DR: Expression of murine differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 109: 1207-1217, 1989.
18. Hatoum A, El-Sabban ME, Khoury J, Yuspa SH and Darwiche N: Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis. Carcinogenesis 22: 1955-1963, 2001.
19. Zou H, Henzel WJ, Liu X, Lutschg A and Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413, 1997.
20. Young-Joon S: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
21. Valko M, Rhodes CJ, Moncol J, Izakovic M and Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160: 1-40, 2006.
22. Yuspa SH: The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis-thirty-third clowes memorila award lecture. Cancer Res 54: 1178-1189, 1994.
23. Robles AI, Rodriguez-Puebla ML, Glick AB and Trempus C: Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway. Genes Dev 12: 2469-2474, 1998.
24. Hochhauser D: Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer. Anticancer Drugs 8: 903-910, 1997.
25. Cip1/Wf1 in differentiation of primary mouse keratinocytes independent cell cycle control. Science 280: 1069-1072, 1998.
26. Aggarwal B and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421, 2006.
27. Loercher A, Lee TL, Ricker JL, et al: Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res 64: 6511-6523, 2004.
28. Budunova IV, Perez P, Vaden VR, Spiegelman VS, Slaga TJ and Jorcano JL: Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Oncogene 18: 7423-7431, 1999.
29. Bhatia N, Herter JR, Slaga TJ, Fuchs SY and Spiegelman VS: Mouse homologue of HOS (mHOS) is overexpressed in skin tumors and implicated in constitutive activation of NF-kappaB. Oncogene 21: 1501-1509, 2002.
30. Bell S, Degitz K, Quirking M, Jilg N, Page S and Brand K: Involvement of NF-kappaB signalling in skin physiology and disease. Cell Signal 15: 1-7, 2003.
31. Martin-Oliva D, O'Valle F, Munoz-Gamez JA, et al: Crosstalk between PARP-1 and NF-kappaB modulates the promotion of skin neoplasia. Oncogene 23: 5275-5283, 2004.
32. Karin M and Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227, 2002.
33. Dajee M, Lazarov M, Zhang JY, et al: NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639-643, 2003.
34. Maeda S, Kamata H, Luo JL, Leffert H and Karin M: IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121: 977-990, 2005.
35. Pasparakis M, Courtois G, Hafner M, et al: TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417: 861-866, 2002.
36. Van Hogerlinden M, Rozell BL, Ahrlund-Richter L and Toftgard R: Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/ nuclear factor-kappaB signaling. Cancer Res 59: 3299-3303, 1999.
37. Van Hogerlinden M, Rozell BL, Toftgard R and Sundberg JP: Characterization of the progressive skin disease and inflammatory cell infiltrate in mice with inhibited NF-kappaB signaling. J Invest Dermatol 123: 101-108, 2004.
38. Zhang S, Ong CN and Shen HM: Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells. Cancer Lett 208: 143-153, 2004.
39. Seitz CS, Lin Q, Deng H and Khavari PA: Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc Natl Acad Sci USA 95: 2307-2312, 1998.
40. Kucharczak J, Simmons MJ, Fan Y and Ge'linas C: To be, or not to be: NF-κB is the answer - role of Rel/NF-κB in the regulation of apoptosis. Oncogene 22: 8961-8982, 2003.
41. Choi JH, Ha J, Park JH, et al: Costunolide triggers apoptosis in human leukemia U937 cells by depleting intracellular thiols. Jpn J Cancer Res 93: 1327-1333, 2002.
42. Wen J, You KR, Lee SY, Song CH and Kim DG: Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide. J Biol Chem 277: 39954-38964, 2002.
43. Vajs V, Todorovic N, Ristic M, et al: Guaianolides from centaurea nicoli: antifungal activity. Phytochem 52: 383-386, 1999.
44. El-Najar N, Dakdouki S, Darwiche N, El-Sabban M, Saliba NA and Gali-Muhtasib H: Anti-colon effects of Salograviolide A isolated from Centaurea ainetensis. Oncol Rep 19: 897-904, 2008.